scorecardresearch
Add as a preferred source on Google
Thursday, November 20, 2025
TopicNovartis

Topic: Novartis

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

In Delhi hospitals, thalassemia patients suffer as life-saving Desferal scarce, set to become 50% costlier

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no shortage in supply.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

It’ll take more than vaccines to fight Covid, Novartis CEO Narasimhan says

Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.

On Camera

Hasina’s was a trial in absentia, but not a trial without justice

The Sheikh Hasina trial represents an inflection point in the struggle to place citizens above rulers and prevent the next massacre.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Can’t stay behind tech curve anymore, must catch up—Vice Chief of Navy Staff ahead of Swavlamban 2025

New Delhi: Noting that India cannot afford to stay behind the technology curve when it comes to war-fighting, Vice Chief of the Naval Staff...

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.